300357.SZ
300357.SZ
CNE100001R58
WOLWO PHARMA
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 1.062.404.471 925.394.525
14.8%
Cost of Revenue 50.582.171 44.809.560
12.9%
Gross Profit 1.011.822.300 880.584.965
14.9%
597.411.172 548.019.035
9.0%
Operating Income 414.411.128 332.565.930
24.6%
Pretax Income 432.705.375 365.061.773
18.5%
Net Income Common Stockholders 380.940.984 317.822.382
19.9%
-- --
--
-- --
--
ende